Fesoterodine a new effective and well-tolerated antimuscarinic for the treatment of urgency-frequency syndrome: results of a phase 2 controlled study.
Chapple C1 1. Royal Hallamshire Hospital
|
|
Abstract 142
|
|
|
Clinical Pharmacology and Overactivity - Blue Room:Chaired by Harold Drutz and Alan Wein
Scientific Podium Poster Session 16
|
|
|
Friday 27th August 2004 |
|
|
14:23 - 14:30 |
|
|